Device Cardiac Arrhythmias and Heart Failure

Aortix System

Payments companies reported to CMS as associated with Aortix System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$155Kassociated payments (2023-2025)
251clinicians with associated payments
2companies reporting

By year

2023 $36K
2024 $53K
2025 $65K

Payments reported as associated with Aortix System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $55K
Advanced Heart Failure and Transplant Cardiology $31K
Hospitalist $18K
Nephrology (Internal Medicine) $9,422
Interventional Cardiology $7,607
Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,222

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Aortix System

These are the largest totals companies reported as associated with Aortix System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Marat Fudim Durham, NC Cardiovascular Disease $34,694.06
Oliver Abela Fort Myers, FL Hospitalist $18,090.47
Palak Shah Falls Church, VA Advanced Heart Failure and Transplant Cardiology $14,625.00
Roy Mathew Columbia, SC Nephrology (Internal Medicine) $9,285.50
Carey Kimmelstiel Boston, MA Cardiovascular Disease $8,225.00
Jennifer Cowger Detroit, MI Advanced Heart Failure and Transplant Cardiology $6,795.06
Ashraf Sabe Providence, RI Thoracic Surgery (Cardiothoracic Vascular Surgery) $4,200.00
Sunit-Preet Chaudhry Indianapolis, IN Advanced Heart Failure and Transplant Cardiology $4,141.32
Sanjeev Gulati Charlotte, NC Cardiovascular Disease $3,733.27
Brian Jefferson Nashville, TN Interventional Cardiology $2,925.00

Prescribed Aortix System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.